NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Formation Bio

Formation Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.formation.bio/

Last Round

Series D

Jun 26, 2024

Est. Valuation

$1B

Total Funding Raised

$633.5M

Momentum

Quiet

No recent growth signals

Company Overview

Formation Bio is a biotechnology company that operates an AI-native drug development platform to acquire, in-license, and accelerate the development of clinical-stage pharmaceutical assets.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug development platformclinical trial optimizationdrug development aiai drug discoveryclinical asset acquisitiontech-bioai-native pharmaCROcontract research organizationclinical trial executiondrug licensingai agentsbiotech unicornmilestone-based agreementspharmaceutical pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Formation Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Formation Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJun 26, 2024
Series CSep 30, 2021
Series BOct 31, 2018
Series ANov 16, 2017
SeedNov 1, 2016

Key People

Founding team and executive leadership

Linhao Zhang

Co-founder CTO

Founding Team

Benjamine Liu

CEO And Co-founder At Formation Bio

Founding Team

Dan Neil

Chief Technology Officer

Executive Team

James Leslie

Chief Financial Officer

Executive Team

Formation Bio Investors

Notable investors and investment history

InvestorRounds
Andreessen HorowitzSeries D
S32Series C
MaveronSeries A, Series B, Seed
SV AngelSeries D
Founder CollectiveSeries A, Series B, Seed
Thrive CapitalSeries C, Series D, Series B
Streamlined VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 2, 2025

    Former Pfizer CSO Mikael Dolsten joins as advisor.

  • Jun 1, 2024

    $372M round led by Andreessen Horowitz.

Formation Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Formation Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Formation Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range196
Year Founded2016
Last FundingJun 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.